Skip to main content
. 2021 May 11;9(5):e27614. doi: 10.2196/27614

Figure 6.

Figure 6

The proportion of proteins covered by CHM or WM specific to DKD. WM aimed more specifically at DKD-related proteins. ACEi: angiotensin-converting enzyme inhibitor; ARB: angiotensin receptor blocker; CHM: Chinese herbal medicine; DKD: diabetic kidney disease; GLP-1: glucagon-like peptide-1; SGLT2i: sodium-glucose cotransporter 2 inhibitors; WM: Western medicine.